DK5-31606-46760
4 vaccinations
2 coded responses
46 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 752 / TX
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
- 2021-02-28
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-14
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-21
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
-
2021-05-02
Survey response — day 42, dose 2MedDRA: Headache — Feeling: GoodFree text: Headaches worse. May be because of reduced caffeine intake or excess stressMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-20
-
2021-09-19
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Nausea, vomiting, muscle aches, fatigue (related to pregnancy)MedDRA releases: 2024-11 · check-in free text available
-
2021-09-19
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-20
-
2021-12-17
Dose 3 — Pfizer-BioNTech
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-23
- 2021-12-24
- 2022-01-02
- 2022-01-07
- 2022-01-15
- 2022-01-21
- 2022-01-30
- 2022-03-18
- 2022-06-17
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-16
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-18
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-09-23
- 2022-10-07
- 2022-10-14
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 42, dose 2
Symptoms: Headaches worse. May be because of reduced caffeine intake or excess stress
Release 9 — 6 months, dose 2
Symptoms: Nausea, vomiting, muscle aches, fatigue (related to pregnancy)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release